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Introduction
Community acquired pneumonia (CAP) is a common
infectious disease worldwide. It is a serious condition
associated with significant morbidity and potential long-
term mortality.1 Each year in the United States, about 1
million people are hospitalised with pneumonia, and
about 50,000 people die from the disease.2 An analysis of
the data from the National Health Survey of Pakistan
1990-94 indicates that prevalence for lifetime pneumonia
was 10% (95% confidence interval [CI] 8%, 12%).3 Due to
the high rate of hospitalisation, CAP causes substantial
economic burden; this can be reduced by treating low-risk
patients as outpatients with effective antimicrobial
treatment.4,5
Medical practitioners come across different severity levels
of CAP — from mild non-severe to severe fatal —
associated with different mortality rates. Earlier studies
demonstrated that medical practitioners either
overestimated the risk in CAP patients and hospitalised
them instead of treating them at home, or
underestimated the severity and treated them as
outpatients.6,7 The decision about the site-of-care i.e.,
home, hospital or emergency department, is very
important, since it has an impact on the quality and cost
of treatment.8 The decision of hospital admission is very
crucial, as even a relatively small decrease in hospital stay
can decrease the hospitalisation cost substantially.9
CAP is diagnosed by recording history, physical
examination of clinical features (cough, fever, pleuritic
chest pain, etc.), radiological examination (chest X-ray),
and laboratory testing (blood culture, sputum culture,
etc.).10,11 In patients with suspected or diagnosed CAP,
medical practitioners should identify high-risk and low-
risk patients, and decide the need for hospitalisation
versus outpatient management, respectively.10 The
Confusion, Uraemia, Respiratory rate, Blood pressure, age
> 65 years (CURB65) score, with one point for each of
Confusion, Urea >7 mmol/l, Respiratory rate >30/min, low
systolic (<90 mm Hg) or diastolic (<60 mm Hg) Blood
pressure, age >65 years (CURB65 score), based on
information available at initial assessment, enables
patients to be stratified according to increasing risk of
mortality.10 International guidelines, including the British
Thoracic Society (BTS) and the Infectious Diseases Society
of America/American Thoracic Society (IDSA/ATS),
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Abstract
Objective: To estimate the proportion of community-acquired pneumonia patients with disagreement between
Confusion, Uraemia, Respiratory rate, Blood pressure, age > 65 years recommendation and physician's decision to
hospitalise or not.
Methods: This cross-sectional nation-wide, non-interventional, cross-sectional study was carried out across 10 cities
of Pakistan from December 2011 to May 2012, and recruited consenting adult patients with confirmatory diagnosis
of community-acquired pneumonia on chest X-ray. Confusion, Uraemia, Respiratory rate, Blood pressure, age > 65
years recommendation for each patient was determined at the time of analysis. This recommendation was
compared with treatment decision made by the physician. Disagreement was considered when the physician's
decision did not match with the recommendation. SPSS 18 was used for data analysis.
Results: Of the 352 patients, 201(57.10%) were males. The overall mean age was 50.67±18.45 years. In 140(39.77%)
patients there was disagreement between Confusion, Uraemia, Respiratory rate, Blood pressure, age > 65 years
recommendation and physician's decision regarding hospitalisation or outpatient care. Of the 352 cases
132(37.50%) were hospitalised despite the recommendation of outpatient treatment.
Conclusion: In almost four out of every 10 patients there was disagreement between Confusion, Uraemia,
Respiratory rate, Blood pressure, age > 65 years recommendation and the physician's decision regarding
hospitalisation of community-acquired pneumonia patients.
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recommend determination of CURB65 score along with
clinical judgment.12,13
In general, emergency department (ED) physicians
appear to use clinical judgement to assess the severity of
CAP rather than using severity assessment tools.11 In
Pakistan, physicians are likely to rely on subjective
impressions of patients' clinical presentation in making
the initial decision about the site-of-care. To the best of
our knowledge, there is no data available in Pakistan on
the site-of-care decision for patients with CAP.
The current study is the first of its kind in Pakistan and was
planned to estimate the proportion of patients in whom
there is disagreement between the recommendation of
CURB65 and the physician's decision of inpatient or
outpatient care. The secondary objectives of the study
were to describe the profile of patients in whom
discordant decisions were made, to identify reasons for
the discordant decisions, and to document the empirical
antibiotic management of CAP patients.
Patients and Methods
The nation-wide, non-interventional, cross-sectional
study was carried out between December 2011 and May
2012 across 10 cities of Pakistan. The studywas conducted
according to the guidelines of Good Epidemiological
Practice (International Epidemiological Association,
2007),14 the principles of the Declaration of Helsinki
(2008)15 and all local laws and regulations. It was
approved by the Ethical Review Committee of the Aga
Khan University, Karachi, and written informed consent
was obtained from all the participants.
There were 22 investigators selected through
convenience sampling from Lahore, Multan, Faisalabad,
Karachi, Hyderabad, Tando Allah Yar, Kotri, Sukkur,
Islamabad and Peshawar. These were medical internists
who provided care to ambulatory patients in a hospital
setting.
Consecutive adult patients, of either gender meeting the
inclusion criteria were enrolled. These patients had new or
increased cough or sputum production, fever >100°F
(>37.8°C), and pulmonary infiltrate on chest X-ray to
confirm the CAP diagnosis.
Those excluded had one or more of the following
conditions: hospitalisation within the preceding 10 days
(suspected hospital-acquired pneumonia), presence of an
emerging alternative diagnosis (e.g. pulmonary or septic
emboli, pulmonary oedema, or malignancy), clinical or
radiological feature strongly indicative of tuberculosis, or
post-obstructive pneumonia due to lung cancer.
A case report form (CRF) was filled during consultation for
each patient meeting the inclusion criteria. The details
collected included patient's characteristics, clinical
features, co-morbid conditions, radiographic findings,
laboratory test of blood urea nitrogen (BUN), reasons for
decision on inpatient admission or outpatient treatment,
and the empiric antibiotics prescribed.
The CURB65 prediction tool was administered at the time
of data analysis to determine the recommendation for
each individual patient. The following criteria of the tool
were evaluated: age >65 years, presence of confusion,
BUN >20 mg/dL (7.14 mmol/L), respiratory rate >30
breaths per minute, and blood pressure (systolic <90 mm
Hg or diastolic <60 mm Hg). For each positive criterion, a
score of one was assigned. Total score was determined by
summation. The recommendations according to the
CURB65 prediction tool are: for a score of 0 or 1 point,
treat as outpatient; for >2 points treat as inpatient.10
Physician's decisions were recorded as categorical
variable (inpatient/outpatient). CURB65
recommendation was compared with the treatment
decision made by the physician. Disagreement was
considered when the physician's decision did not match
with the CURB65 recommendation.
The proportion of patients with a disagreement between
CURB65 recommendation and physician's decision of
inpatient or outpatient treatment was documented.
For primary and secondary analyses, all categorical
variables were analysed as frequencies and percentages.
Continuous variables were reported as means with
standard deviations (SD). SPSS 18 was used to analyse the
data.
Since there is no information available in Pakistan on the
proportion of patients with disagreement between
CURB65 recommendation and physician's decision, it was
assumed that 50% of patients would have a discordant
decision. For a 95% confidence level, a margin of error of
5%, and accounting for approximately 10% inaccurate
completion of CRFs, the sample size required was
estimated as 425.
Results
There were 466 eligible patients, but for the purpose of
analysis, only 352(75.5%) patients were available for
whom BUN test was done at consultation.
The overall mean age of these 352 patients was
50.67±18.45 years and 201(57.10%) of them were men.
Patients reported having fever for a mean duration of
6.76±4.39 days. There were 74(21.02%) current smokers
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(Table-1). Based on the CURB65 criteria, there were
100(28.40%) patients aged >65 years; confusion was
present in 63(17.89%) patients; BUN was >20 mg/dL in
109(30.96%); respiratory rate was >30 breaths per minute
in 67(19.03%); systolic blood pressure (SBP) was <90
mmHg or diastolic blood pressure (DBP) <60 mm Hg in
57(16.19%) patients.
In 140(39.77%) patients there was a disagreement
between CURB65 recommendation and the physician's
decision of inpatient or outpatient care. Among these, 132
(37.50%) cases were admitted despite CURB65
recommendation of outpatient treatment. According to
CURB65 criteria, 8(2.27%) patients were at intermediate or
high risk of mortality and needed inpatient care. However,
these patients' risks were underestimated by the
physicians (Table-2).
Of the 140 patients with discordant decisions, 82(58.57%)
were men. The mean age of these patients was
51.14±16.31 years, and 27(19.28%) were >65 years of age.
Confusion was present in 3.57% (5/140) of patients. The
mean respiratory rate was 24.55±4.77 breaths/minute,
and 14(10.00%) patients had a respiratory rate of >30
breaths/minute. The mean SBP was 125.22±20.60mmHg,
and DBP was 77.44±10.41mmHg, with 10(7.14%) patients
having either SBP<90 mmHg or DBP <60 mmHg or both.
The mean BUN was 17.46±13.21mg/dL with 30(21.42%)
patients having BUN of >20 mg/dL. Patients reported
having fever for a mean duration of 7.02±4.78 days. There
were 28(20%) current smokers.
The most common symptoms were fatigue in 110(78.57%)
patients and dyspnoea in 107(76.42%). On auscultation
crackles were heard in 118(84.28%) patients, with
decreased breath sounds in 78(55.71%). Chest X-ray
revealed lobar consolidation in 95(67.85%) patients, and
J Pak Med Assoc
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Table-1: Patient Characteristics.
Parameters Total Patients with
patients discordant
(N = 352) decisions (N = 140)
Age (years), mean ± SD 50.67 ± 18.45 51.14 ± 16.31
Height (cm), mean ± SD 160.64 ± 11.49 160.43 ± 10.99
Weight (kg), mean ± SD 66.27 ± 16.82 70.04 ± 18.98
Body temperature (°F), mean ± SD 101.71 ± 1.22 101.51 ± 1.07
Duration of fever (days), mean ± SD 6.76 ± 4.39 7.02 ± 4.78
Gender, n (%)
Male 201 (57.10) 82 (58.57)
Female 148 (42.04) 57 (40.71)
Missing 3 (0.85) 1 (0.71)
Respiratory rate (breaths perminute), mean± SD 24.89± 5.54 24.55± 4.77
SBP (mm Hg), mean ± SD 119.38 ± 20.12 125.22 ± 20.60
DBP (mm Hg), mean ± SD 74.72 ± 11.58 77.44 ± 10.41
Blood urea nitrogen (mg/dL), mean ± SD 20.00 ± 15.87 17.46 ± 13.21
Current smoker, n (%) 74 (21.02) 28 (20.00)
Former smoker, n (%) 77 (21.87) 30 (21.42)
DBP: Diastolic blood pressure
SBP: Systolic blood pressure
SD: Standard deviation.
Table-2: Comparison between CURB65 recommendation and physician's decision (N=
352).




CURB65: Confusion, Uremia, Respiratory rate, Blood pressure, age >65 years.
Table-3: Clinical presentation and comorbid diseases in patients with discordant
decisions (N = 140).






Pleuritic Chest Pain 80 (57.14)
Dullness on percussion 63 (45.00)




Normal breath sounds 19 (13.57)
Bronchial breath sounds 69 (49.28)





Pulmonary infiltrate 140 (100.00)
Lobar consolidation 95 (67.85)
Patchy infiltrates 41 (29.28)
Pleural effusion 41 (29.28)
Atelectasis 2 (1.42)
Extent of Pneumonia
Confined to 1 lobe 87 (62.14)
>1 lobe 42 (30.00)
Comorbid diseases
Diabetes mellitus 49 (35.00)
Hypertension 43 (30.71)
Chronic obstructive pulmonary disease 26 (18.57)
Ischaemic heart disease 23 (16.42)
Asthma 18 (12.85)
Pulmonary Fibrosis 8 (5.71)
Others 17 (12.14)
pneumonia confined to one lobe in 87(62.14%). The most
common comorbid disease was diabetes mellitus in
49(35%), followed by hypertension in 43(30.71%) (Table-3).
The three common reasons identified in patients with
discordant decisions were clinical judgment in
127(90.71%), patient's clinical appearance in 118(84.28%)
and comorbid conditions in 85(60.71%) cases. In
36(25.71%) patients, physicians reported failure of
outpatient antibiotic therapy as the reason for their
decision to admit (Table-4).
Of the 352 CAP patients, 99(28.12%) were already on
antibiotics at the time of presentation. Of these, 36(36%)
did not respond to the antibiotics initially prescribed.
At consultation, 135(38.35%) patients were prescribed
monotherapy, the most common being fluoroquinolone:
levofloxacin in 52(14.77%) patients and moxifloxacin in
31(8.80%). Among combination antibiotics, ceftriaxone
was most commonly prescribed to 107 (30.39%) patients,
followed by clarithromycin in 93(26.42%) (Table-5).
Discussion
This cross-sectional study evaluated the physicians'
decision on site-of-care in adult patients suffering from
CAP.We found that in almost 4 out of every 10 cases, there
was disagreement between CURB65 recommendation
and physician's decision of inpatient or outpatient care.
Most of these patients (132/140; 94.28%), who should
have received outpatient treatment, were hospitalised.
In an earlier study in low-risk CAP patients, 36.7% were
inpatients.6 Another study in hospitalised patients
revealed that 14% of low-risk patients with mild CAP
without comorbidities were admitted in spite of CURB65
recommendation for outpatient management.16 In
another study in 1199 hospitalised patients, 46.5%
patients had discordant decisions despite objective
severity assessment as outpatients.17 These earlier studies
were in line with the present study, in which 238 patients
were at low risk (CURB65 score 0 or 1), of whom as many
as 132 (55.5%) patients were hospitalised.
This high rate of discordant decisions by physicians might
be explained by physicians' reliability on clinical
judgment rather than using severity assessment tools.17
An earlier study demonstrated that physicians relied on
respiratory status, comorbid illness, clinical appearance,
lung involvement of >1 lobe, and oral intake, in
hospitalisation decision for low-risk patients.6 The present
study also demonstrated that discordant site-of-care
decisions by the medical practitioners are influenced by
clinical judgment (90.7%), patient's clinical appearance
(84.3%), and comorbid conditions (60.7%).
International guidelines, including BTS and IDSA/ATS
guidelines, recommend using severity-of-illness scores,
along with physician's determination of the patient's
ability to maintain oral intake, availability of outpatient
support resources for likelihood of compliance, patient's
functional status, etc.13 Severity of disease can be
measured by various severity assessment tools, such as
CURB65, CRB65 (same as CURB65 minus uraemia),
Pneumonia Severity Index (PSI), modified ATS, modified
BTS, and Systolic blood pressure, Multilobar involvement,
Albumin, Respiratory rate, Tachycardia, Confusion,
Oxygen level, pH (SMART-COP), depending on which
patients the medical practitioners want to identify.11 The
CURB65 score is a simple tool based on five clinical
features, with an ability to identify low-risk patients.18,19
Implementing the guidelines has been shown to lower
admission rates by using severity assessment score for
determining disease severity.20,21
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Table-4: Reasons for discordant decisions (N = 140).
Reasons N (%)
Clinical judgment 127 (90.71)
Patient's clinical appearance 118 (84.28)
Very sick 80/118 (57.14)
Not too sick 38/118 (27.14)
Comorbid condition(s) 85 (60.71)
Prediction tools (Inappropriate application) 40 (28.57)
Failure of outpatient antibiotic therapy 36 (25.71)
Lack of access to medication 4 (2.85)
Lack of compliance to medication 20 (14.28)
Others 8 (5.71)
Patients with >1 reasons 123 (87.85)
Missing information 1 (0.71)







Combination drugs 217 (61.64)
Ceftriaxone + clarithromycin 52 (14.77)
Ceftriaxone + levofloxacin 17 (4.82)
Ceftriaxone + moxifloxacin 17 (4.82)
Ceftriaxone + other antibiotics 21 (5.96)
Amoxicillin/clavulanate + clarithromycin 28 (7.95)
Clarithromycin + moxifloxacin 13 (3.69)
Amoxicillin/clavulanate + levofloxacin 12 (3.40)
Other combinations 56 (15.90)
Missing information 1 (0.28)
A recent prospective observational study conducted in
Nigeria demonstrated that CURB65 score is a simple
method of assessing and risk stratifying CAP patients,
which helps to identify a reasonable proportion of low-
risk patients for potential outpatient care.22 However, low
physician awareness and inconsistent recommendations
have shown to be contributing factors for non-adherence
to the CAP guidelines.23,24 A recent retrospective
descriptive study conducted in United Arab Emirates
(UAE) reported that CURB65 was not optimally utilised in
patients with CAP.25 The present study also indicates that
physicians overestimated the risk of their patients in
37.5% of cases. This suggests that physicians need to
apply the CURB65 criteria more frequently and stringently
to avoid irrational hospital admissions. This can help
reduce unnecessary burden on healthcare systems and
avoid contracting of nosocomial infection by patients
otherwise at low risk.
Advanced age, and conditions such as heart failure,
chronic obstructive pulmonary disease (COPD), chronic
liver disease, chronic kidney disease, and diabetes are
known to be the leading comorbidities in patients with
CAP.6.22.26 In an earlier study in Pakistan, the common
comorbid conditions in hospitalised patients with CAP
included hypertension (35.6%), diabetes (29.8%) and
COPD (9.7%).27 In another recent study in Pakistan,
ischaemic heart disease (20%), diabetes (18%) and COPD
(18%) were the common comorbid conditions.28 In our
study, among 140 patients with discordant decisions, the
most common comorbid disease was diabetes mellitus
(35.00%), followed by hypertension (30.71%) and COPD
(18.57%). The fact that 94.3% of these patients were
hospitalised despite being at low-risk could be attributed
to presence of comorbid conditions.
The international guidelines, including the BTS and the
IDSA/ATS, recommend empirical antibiotic treatment in
patients with CAP, since the causative microorganism is
not identified in all the patients. Although these
guidelines are developed in theWestern population, it has
been shown that the core organisms causing CAP in
Southeast Asia are similar to those in the Western
countries.29
As per the IDSA/ATS 2007 guidelines, previously healthy
outpatients should be treated with a macrolide or
doxycycline, while outpatients with comorbidities should
be prescribed fluoroquinolone or combination of -lactam
and macrolide. Inpatients not admitted to intensive care
unit should be prescribed fluoroquinolone or
combination of -lactam andmacrolide, andmonotherapy
is recommended in inpatients without severe disease or
risk factors for infection.13 In the present study, the
majority (61.6%) of CAP patients were empirically
prescribed combination therapy, with ceftriaxone being
most common in 30% of patients. As monotherapy,
levofloxacin was most commonly prescribed (14.8%),
followed by moxifloxacin (8.8%).
This is the first study in Pakistan, to the best of our
knowledge, to evaluate site-of-care decision by
physicians for managing patients with CAP. The study
used CURB65 criteria for evaluation, which is the BTS-
recommended scoring tool. The consecutive patient
recruitment limited bias in selecting patients. In this
exploratory study, though the investigators were selected
by convenience sampling, they represent consultants
having predominant interest and practice in chest
medicine. The study also represents a good mixture of
public and private hospitals in the secondary and tertiary
health care setup in 10 major cities of Pakistan.
Information was collected on real-life clinical practice in
Pakistan. However, the findings need to be cautiously
interpreted as they may not be generalisable to the entire
population. As this was a cross-sectional study,
information on mortality and disease evolution of the
patients were not captured. A prospective study may be
designed to evaluate site-of-care decisions and correlate
with clinically relevant outcomes.
Conclusion
In almost 4 out of every 10 CAP patients, there was a
disagreement between CURB65 recommendation and
the physician's decision of inpatient or outpatient care.
Increased physician awareness and adherence to using
guideline-recommended severity assessment tools for
deciding site-of care would lead to decreased
hospitalisation and economic burden.
Acknowledgments
We are grateful to the following physicians who
participated as investigators: Dr Ahmed Zeeshan, Dr Hanif
Nagra, Dr Masood Javed (Faisalabad); Dr Arif Somroo
(Tando Allah Yar); Dr Arshad Ali Shah (Kotri); Dr Amir Dabir
(Hyderabad); Dr Ehsan ul Haq, Dr Munawar Khan, Dr Fazal
ur Rehman (Islamabad); Dr Zaki Hassan (Karachi); Dr
Khurshid uz Zaman, Dr Mobeen ud Din, Dr Saleem-uz-
Zaman, Dr Talha Mahmud, Dr Zafar Iqbal (Lahore); Dr Arif
Mahmood (Multan); Dr Anila Basit, Dr Zaffar Iqbal
(Peshawar); and Dr Altaf Hussain Ghumro, Dr Shafi
Muhammad (Sukkur). Thanks are also due to Dr (Ms.) Jai
Tilak-Jain and Anahita Gouri from Sanofi, India, for
editorial assistance, and Mr Iqbal Mujtaba from Sanofi,
Pakistan, for statistical assistance.
Disclaimer: The study abstract was presented at the Oral
J Pak Med Assoc
384 S. Ullah, J. Khan, A. Khan, et al
Session of the 11th Pakistan Chest Society (PCS) Biennial
International Conference on Chest Diseases and Lung
Health, held in Islamabad on 18-21 April, 2014.
Conflict of Interest: None.
Source of Funding: The study was funded by Sanofi-
Aventis Pakistan Limited.
References
1. Ramirez JA, Anzueto AR. Changing needs of community-acquired
pneumonia. J Antimicrob Chemother. 2011;66:iii3-iii9.
2. Centers for Disease Control and Prevention. Pneumonia can be
prevented - vaccines can help. [Online] [cited 2015 June 17].
Available from: URL: http://www.cdc.gov/Features/Pneumonia/.
3. Shaikh IA, Shaikh MA. Correlates of self-reported lifetime
pneumonia prevalence in adult Pakistani population. J Ayub Med
Coll Abbottabad. 2007; 19:73.
4. Brown PD. Adherence to guidelines for community-acquired
pneumonia: does it decrease cost of care? Pharmacoeconomics.
2004; 22:413-20.
5. Sicras-Mainar A, Ibanez-Nolla J, Cifuentes I, Guijarro P, Navarro-
Artieda R, Aguilar L. Retrospective epidemiological study for the
characterization of community- acquired pneumonia and
pneumococcal pneumonia in adults in a well-defined area of
Badalona (Barcelona, Spain). BMC Infect Dis. 2012; 12:283.
6. Fine MJ, Hough LJ, Medsger AR, Li YH, Ricci EM, Singer DE, et al.
The hospital admission decision for patients with community-
acquired pneumonia. Results from the pneumonia Patient
Outcomes Research Team cohort study. Arch Intern Med. 1997;
157:36-44.
7. Tang CM, Macfarlane JT. Early management of younger adults
dying of community acquired pneumonia. Respir Med. 1993;
87:289-94.
8. Guest JF, Morris A. Community-acquired pneumonia: the annual
cost to the National Health Service in the UK. Eur Respir J. 1997;
10:1530-4.
9. Kozak LJ, DeFrances CJ, Hall MJ. National Hospital Discharge
Survey: 2004 annual summary with detailed diagnosis and
proprocedure data. National Center for Health Statistics. Vital
Health Stat. 2006; 13:1-209.
10. Watkins RR, Lemonovich TL. Diagnosis and management of
community-acquired pneumonia in adults. Am Fam Physician.
2011; 83:1299-306.
11. Moran GJ, Rothman RE, Volturo GA. Emergency management of
community-acquired bacterial pneumonia: what is new since the
2007 Infectious Diseases Society of America/American Thoracic
Society guidelines. Am J Emerg Med. 2013; 31:602-12.
12. LimWS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et
al. BTS guidelines for the management of community acquired
pneumonia in adults: update 2009. Thorax. 2009; 64 Suppl 3: iii1-55.
13. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD,
Dean NC, et al. Infectious Diseases Society of America/American
Thoracic Society consensus guidelines on the management of
community-acquired pneumonia in adults. Clin Infect Dis. 2007;
44 Suppl 2: S27-72.
14. International Epidemiological Association. Good Epidemiological
Practice (GEP). [Online] [cited 2015 February 7]. Available from
URL: http://ieaweb.org/good-epidemiological-practice-gep/.
15. Williams JR. Revising the Declaration of Helsinki. World Med J.
2008; 54: 120-2.
16. Yongchun S, Fuqiang W, Chun W. Revised admission decision
made for community acquired pneumonia patients with CURB-65.
Chest. 2011; 140:757A.
17. Dean NC, Jones JP, Aronsky D, Brown S, Vines CG, Jones BE, et al.
Hospital admission decision for patients with community-
acquired pneumonia: variability among physicians in an
emergency department. Ann Emerg Med. 2012; 59: 35-41.
18. Ewig S, de Roux A, Bauer T, Garcia E, Mensa J, Niederman M, et al.
Validation of predictive rules and indices of severity for
community acquired pneumonia. Thorax. 2004; 59:421-7.
19. Man SY, Lee N, Ip M, Antonio GE, Chau SS, Mak P, et al. Prospective
comparison of three predictive rules for assessing severity of
community-acquired pneumonia in Hong Kong. Thorax. 2007;
62:348-53.
20. Suchyta MR, Dean NC, Narus S, Hadlock CJ. Effects of a practice
guideline for community-acquired pneumonia in an outpatient
setting. Am J Med. 2001; 110: 306-9.
21. Hagaman JT, Yurkowski P, Trott A, Rouan GW. Getting physicians to
make "the switch": the role of clinical guidelines in the
management of community-acquired pneumonia. Am J Med
Qual. 2005; 20:15-21.
22. Mbata GC, Chukwuka CJ, Onyedum CC, Onwubere BJ. The CURB-
65 scoring system in severity assessment of Eastern Nigerian
patients with community-acquired pneumonia: a prospective
observational study. Prim Care Respir J. 2013; 22:175-80.
23. Switzer GE, Halm EA, Chang CC, Mittman BS, Walsh MB, Fine MJ.
Physician awareness and self-reported use of local and national
guidelines for community-acquired pneumonia. J Gen Intern
Med. 2003;18:816-823.
24. Flanders SA,HalmEA.Guidelines for community-acquiredpneumonia:
are they reflected in practice?Treat RespirMed. 2004; 3:67-77.
25. Alomar MJ, Al-Ahmad MM. Evaluation of hospital admission
criteria for community acquired-pneumonia patients at a private
hospital in UAE. J Pharm Res. 2013; 7:267-70.
26. Menendez R, Cavalcanti M, Reyes S, Mensa J, Martinez R, Marcos
MA, et al. Markers of treatment failure in hospitalized community
acquired pneumonia. Thorax 2008; 63:447-52.
27. Irfan M, Hussain SF, Mapara K, Memon S, Mogri M, Bana M, et al.
Community acquired pneumonia: risk factors associated with
mortality in a tertiary care hospitalized patients. J Pak Med Assoc.
2009; 59:448-52.
28. Zubairi ABS, Zafar A, Salahuddin N, Haque AS,Waheed S, Khan JA.
Atypical pathogens causing community-acquired pneumonia in
adults. J Pak Med Assoc. 2013; 62:653-56.
29. Wattanathum A, Chaoprasong C, Nunthapisud P, Chantaratchada
S, Limpairojn N, Jatakanon A, et al. Community-acquired
pneumonia in southeast Asia: the microbial differences between
ambulatory and hospitalized patients. Chest. 2003; 123:1512-9.
Vol. 67, No. 3, March 2017
Assessing decision of inpatient or outpatient care in community acquired pneumonia: APT care study 385
